Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.419 | Dysarthric Speech Pattern Detection, Analysis and Reconstruction for Rehabilitation Training |
Prof. MENG Mei-Ling, Helen 蒙美玲 |
| 2021.235 | Non-invasive diagnosis for Ankylosing Spondylitis via a single-cell multi-omics approach |
Dr. MIU Kai Kei 繆啟基 |
| 2024.712 | The perceptions and experiences of movement behaviours in individuals with coronary heart disease after cardiac rehabilitation: A qualitative study | Ms. MIU Yi Ning |
| 2013.503 | A randomized controlled study to evaluate the efficacy of a positive psychology and social networking intervention in reducing depressive symptoms among HIV-infected men who have sex with men in China | Prof. MO Phoenix Kit Han |
| 2022.316 | Individual basic body awareness therapy (BBAT) as an add-on treatment for dyspnea self-management in patients with chronic obstructive pulmonary disease (COPD) - a quantitative and qualitative study |
Mr MO Kim Chung 巫劍聰 |
| 2022.486 | The roles of community physiotherapy in COVID-19 patient management: case reports |
Mr. MO Kim Chung 巫劍聰 |
| 2018.152 | Does additional weekend and holiday physiotherapy benefit geriatric hip fracture patients? A case-control study to evaluate clinical outcomes |
Mr. MO Kim Chung 巫劍聰 |
| 2014.274 | The efficacy of using online narratives in changing HIV risk perceptions and behaviours among men who have sex with men in Hong Kong | Prof. MO Phoenix Kit Han |
| 2025.028 | A multi-faceted self-management intervention for improving patient activation and lifestyle behavior modification among people with cardiometabolic multimorbidity: A pilot randomized controlled trial | Prof. MO Phoenix Kit Han |
| 2024.580 | A longitudinal study for examining the effect of Internet gaming disorder on internalizing and externalizing behaviours among Hong Kong adolescents | Prof. MO Phoenix Kit Han |
| 2022.603 | Mitigating loneliness of older adults through cognitive behavioral approach and peer and family support: A randomized controlled trial | Prof. MO Phoenix Kit Han |
| 2023.009 | Translating condom use intention to action among Chinese men who have sex with men: The role of volitional factors | Prof. MO Phoenix Kit Han |
| 2021.408 | A randomized controlled trial to evaluate efficacy of a brief online integrated self-affirmation and implementation intention intervention in improving medication adherence among uncontrolled hypertensive patients | Prof. MO Phoenix Kit Han |
| 2014.348 | Positive psychology intervention for parents of children with Attention Deficit Hyperactivity Disorder (ADHD): Randomized controlled trial | Research Assistant Professor Mo Phoenix Kit Han |
| 2014.347 | A randomised controlled trial evaluating efficacy of a psychological intervention based on Commonsense Model in improving mental health and self-care among Type-2 Diabetes Mellitus patients | Prof. MO Phoenix Kit Han |
| 2016.720 | A cluster randomized controlled trial to test the efficacy of a theory-based and setting-based intervention in promoting strength training among older adults in Hong Kong |
Ms. MO Phoenix Kit Han 巫潔嫻 |
| 2017.429 | Can Positive Psychological Intervention (PPI) improve psychological well-being among Chinese University students? A randomized control trial of Best Possible Self (BPS) Intervention |
Dr. MO Phoenix Kit Han 巫潔嫻 |
| 2017.062 | Positive Psychology Intervention in improving emotion regulation and risky sexual behaviors among men who have sex with men - a randomized controlled trial |
Prof. MO Phoenix Kit Han 巫潔嫻 |
| 2013.043 | Effectiveness of an Integrated Social Skills Training (ISST) with Social Cognition Component for people with Schizophrenia: A Clinical Control Trial | Ms Mo Sung Yu, Chloe |
| 2020.099 | Hong Kong Real-World Data Analytics and Genomic-Guided Therapy Research Project | Dr. MOK Florence Siu Ting |
| 2016.355 | Burnout among physician engaged in palliative care in Hong Kong public hospitals -- BUPPALHO study | Dr. MOK Alice Ka Wai |
| 2017.612 | A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease (AD) |
Prof. MOK Chung Tong 莫仲棠 |
| 2014.221 | Pilot study on Microelectronic Neural Bridge in improving rehabilitation outcome for stroke patients with upper limb paresis | Professor MOK chung tong Vincent |
| 2009.593 | A 78-Week Noninterventional Longitudinal Study to Validate the Alzheimer | Prof. Mok Chung Tong Vincent |
| 2007.502 | Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release to 10 mg Donepezil Immediate Release in Patients with Moderate to Severe Alzheimer | Professor Mok Chung Tong Vincent |
| 2008.319 | Effect of LY450139, A | Dr MOK Chung Tong, Vincent |
| 2007.454 | Occupational and Parkinson's Disease in Hong Kong - A Case-Control Study | Prof. MOK Chung Tong, Vincent |
| 2009.497 | Follow-up of a randomized clinical trial ("ViNeuro"): Incidence of Cognitive decline and dementia in Chinese Parkinson's disease patients | Prof Mok Chung Tong, Vincent |
| 2020.394 | Corneal Nerve Changes in Herpes Zoster Ophthalmicus |
Dr. MOK Eugenie 莫曉瑜 |
| 2024.700 | Comparing efficacy of oral azithromycin versus topical azithromycin in the treatment of meibomian gland dysfunction using in vivo confocal microscopy | Dr. MOK Eugenie |
| 2014.477 | Phase II Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) | Dr. MOK Florence Siu Ting |
| 2020.463 | Outcomes and hearing loss after definitive Intensity Modulated Radiotherapy (IMRT) in Nasopharyngeal carcinoma: Dose effect and toxicity relationship |
Dr. MOK Florence Siu Ting 莫小婷 |
| 2020.472 | Retrospective Cohort Study of Lung Cancer in Hong Kong |
Dr. MOK Florence Siu Ting MOK 唐美思 |
| 2011.232 | Sleep Disturbance in Chinese Palliative Care Patients and Its Impact on Quality of Life | Dr Mok Ka Wai Alice |
| 2017.028 | Relationship between knee kinematics and functional performance during an isometric single-leg squat |
Dr. MOK Kam Ming 莫鑑明 |
| 2013.645 | Clinical siginificance and functional effects of NCOA2 in colorectal cancer | Dr Mok Myth Tsz Shun |
| 2010.083 | High Performance Multi-pinhole SPECT for Clinical and Preclinical Molecular Imaging | Dr Mok Seng Peng, Greta |
| 2013.448 | Streamlining workflow by using water instead of iodinated oral contrast for CT Abdomen & Pelvis | Ms. MOK Serena Sum Yee |
| 2022.334 | HERTHENA–Lung02: A Phase 3, Randomized, Open-label Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced Epidermal Growth Factor Receptor-mutated (EGFRm) Non-small Cell Lung Cancer (NSCLC) After Failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy |
Prof. MOK Shu Kam 莫樹錦教授 |
| 2012.225 | A Randomized, Phase III, Multicenter, Double Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of MetMAb in Combination With Tarceva (Erlotinib) in Patients with Met Diagnostic-Positive Non-Small Cell Lung Cancer (NSCLC) who have Received Standard Chemotherapy for Advanced or Metastatic Disease | Prof. Mok Shu-Kam |
| 2020.341 | To determine the clinical effect of Local ablative radiotherapy such as stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS) on various metastatic cancers | Dr. MOK Siu Ting |
| 2016.229 | Stereotactic Radiosurgery (SRS)/ Radiotherapy (SRT) for Brain Metastases: A Review of Outcomes and Prognostic Scores Evaluation |
Dr Mok SIU TING 莫小婷 |
| 2005.209 | The Health-Related Quality of Life of Chronic Hepatits B Carriers in Hong Kong | MOK Suet Yuk |
| 2013.021 | A Survey of the Current Status of EGFR Mutation Testing in Asia | Prof. Mok Tony |
| 2010.228 | Mapping of activating and resistant EGFR mutations in pulmonary adenocarcinoma | Professor Mok Tony |
| 2011.602 | A Phase III Randomised, Double blind, Placebo controlled, Parallel, Multicentre Study to Assess the Efficacy and Safety of continuing IRESSATM 250 mg in addition to Chemotherapy versus Chemotherapy alone in Patients who have Epidermal Growth Factor Receptor (EGFR) Mutation Positive Locally advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and have progressed on First Line IRESSATM. IMPRESS- (IRESSATM Mutation Positive Multicentre Treatment Beyond ProgRESsion Study) | Prof. MOK Tony |
| 2011.396 | A Randomized Double Blind Phase 3 Efficacy And Safety Study Of PF-00299804 Versus Erlotinib For The Treatment Of Advanced Non-Small Cell Lung Cancer Following Progression After, Or Intolerance To, At Least One Prior Chemotherapy | Prof. MOK Tony |
| 2009.331 | Clinical Application of Epidermal Growth Factor Receptor (EGFR) Mutation as Predictive Biomarker for EGFR Tyrosine Kinase Inhibitor (TKI) in Never/Light-Smoker with Adenocarcinoma of Lung | Prof. MOK Tony |
| 2014.257 | A Phase II, Open Label, Single-arm Study to Assess the Safety and Efficacy of AZD9291 in Patients with Locally Advanced/Metastatic Non Small Cell Lung Cancer whose Disease has Progressed with Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and whose Tumours are Epidermal Growth Factor Receptor Mutation and T790M Mutation Positive (AURA2) | Prof. MOK Tony |
| 2009.392 | LUX-Lung 3; A randomised, open-label, phase III study of BIBW 2992 versus chemotherapy as first-line treatment for patients with stage IIIB or IV adenocarcinoma of the lung harbouring an EGFR activating mutation | Prof. MOK Tony |
Page 170 of 262.